Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × polatuzumab vedotin × 30 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 6 Lymphoma, Non-Hodgkin 3 Lymphoma, B-Cell 2 Lymphoma 2 Recurrence 1 Neoplasms 1 Leukemia, Hairy Cell 1 Hodgkin Disease 1 Burkitt Lymphoma 1

Interventions

venetoclax 23 ibrutinib 13 Rituximab 13 Cyclophosphamide 13 obinutuzumab 10 fludarabine 9 pirtobrutinib 8 Specimen Handling 7 zanubrutinib 6 Biopsy 6 Bendamustine Hydrochloride 6 acalabrutinib 5 fludarabine phosphate 4 Whole-Body Irradiation 4 Prednisone 4 Lenalidomide 4 Vincristine 3 Mycophenolic Acid 3 Magnetic Resonance Spectroscopy 3 Doxorubicin 3 CT-P10 3 idelalisib 2 Tacrolimus 2 Surveys and Questionnaires 2 Granulocyte Colony-Stimulating Factor 2 Cyclosporine 2 Chlorambucil 2 ARQ531 2 voruciclib 1 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡